MEDICINOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 0.00 shares.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 3.00K shares, a 99.17% decline from fiscal 2021.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 360.95K shares, a 25.39% increase from fiscal 2020.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 287.86K shares, a 71.72% decline from fiscal 2019.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 1.02M shares, a 711.74% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-13 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 3.00K shares 10-K · filed 2024-02-15 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2021-12-31 | 15.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | 360.95K shares 10-K/A · filed 2023-03-28 |
| 2021-09-30 | 104.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 429.95K shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-06-30 | 155.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 385.87K shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-03-31 | 86.25K shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 84.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | 287.86K shares 10-K · filed 2022-02-16 |
| 2020-09-30 | 60.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | |
| 2019-12-31 | 2.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | 1.02M shares 10-K · filed 2021-02-19 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | 1.02M shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-06-30 | 38.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | 1.02M shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-03-31 | 977.45K shares 10-Q · filed 2019-04-25 | 977.45K shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 125.39K shares 10-K · filed 2020-02-13 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | 194.46K shares derived: sum of 4 quarters · filed 2019-10-24 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | 230.97K shares derived: sum of 4 quarters · filed 2019-07-25 |
| 2018-03-31 | 125.39K shares 10-Q · filed 2019-04-25 | 230.97K shares derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | 69.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 105.58K shares 10-K · filed 2019-02-13 |
| 2017-09-30 | 36.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | 36.51K shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | 13.30K shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-04-25 | 42.77K shares derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 172.59K shares 10-K · filed 2019-02-13 |
| 2016-09-30 | 13.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | 172.59K shares derived: sum of 4 quarters · filed 2017-10-23 |
| 2016-06-30 | 29.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | 159.28K shares derived: sum of 4 quarters · filed 2017-07-26 |
| 2016-03-31 | 129.82K shares 10-Q · filed 2017-04-26 | 129.82K shares derived: sum of 4 quarters · filed 2017-04-26 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 0.00 shares 10-K · filed 2016-02-25 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-25 | 5.00K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | 20.00K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2016-04-27 | 20.00K shares derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | 20.00K shares 10-K · filed 2017-02-14 |
| 2014-09-30 | 15.00K shares 10-Q · filed 2015-10-29 | 15.00K shares derived: sum of 4 quarters · filed 2015-10-29 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | 0.00 shares derived: sum of 4 quarters · filed 2015-07-30 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | 38.09K shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | 79.46K shares 10-K · filed 2014-03-27 |
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-13 | 79.46K shares derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | 38.09K shares 10-Q · filed 2014-08-13 | 79.46K shares derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-03-31 | 41.38K shares 10-Q · filed 2014-05-08 | 101.38K shares derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | 60.00K shares 10-K · filed 2013-03-28 |
| 2012-09-30 | 0.00 shares 10-Q · filed 2013-11-07 | |
| 2012-06-30 | 60.00K shares 10-Q · filed 2013-08-08 | |
| 2011-09-30 | 921.00 shares 10-Q · filed 2012-11-08 | |
| 2011-06-30 | 30.00K shares 10-Q · filed 2012-08-09 | |
| 2006-12-31 | 1.40K shares 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |